Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,053
Closed -$337K 75
2023
Q2
$337K Buy
3,053
+45
+1% +$5.26K 0.22% 61
2023
Q1
$369K Buy
3,008
+305
+11% +$37.5K 0.32% 53
2022
Q4
$316K Sell
2,703
-4,893
-64% -$493K 0.3% 49
2022
Q3
$631K Sell
7,596
-49
-0.6% -$5.28K 0.72% 32
2022
Q2
$781K Sell
7,645
-12,526
-62% -$1.48M 0.77% 30
2022
Q1
$2.71M Sell
20,171
-12,295
-38% -$1.73M 1.68% 23
2021
Q4
$5.41M Sell
32,466
-15,223
-32% -$2.51M 2.57% 13
2021
Q3
$6.93M Sell
47,689
-779
-2% -$127K 3.28% 7
2021
Q2
$7.49M Sell
48,468
-2,680
-5% -$361K 3.43% 5
2021
Q1
$6.8M Sell
51,148
-125
-0.2% -$17.4K 3.51% 8
2020
Q4
$7.25M Buy
51,273
+965
+2% +$128K 3.83% 3
2020
Q3
$6.32M Buy
50,308
+22,875
+83% +$2.46M 3.86% 2
2020
Q2
$2.69M Sell
27,433
-1,634
-6% -$151K 1.89% 22
2020
Q1
$2.4M Sell
29,067
-13,150
-31% -$1.22M 3.42% 10
2019
Q4
$4.28M Buy
42,217
+709
+2% +$66.8K 2.95% 10
2019
Q3
$3.9M Sell
41,508
-3,490
-8% -$299K 3.03% 10
2019
Q2
$3.78M Sell
44,998
-4,334
-9% -$365K 3.05% 11
2019
Q1
$4.15M Sell
49,332
-3,510
-7% -$290K 3.54% 4
2018
Q4
$3.92M Sell
52,842
-675
-1% -$50.5K 4.53% 3
2018
Q3
$4.53M Buy
53,517
+6,030
+13% +$484K 3.48% 4
2018
Q2
$3.5M Buy
+47,487
New +$3.35M 2.77% 14

Other funds holding NKE

Geneva Partners's NKE Position: Q3 2023 in Review

Geneva Partners sold out of Nike (NKE) in Q3 2023, closing a stake of 3,053 shares — an estimated $337K sold.

Geneva Partners first reported a position in NKE in Q2 2018 and held it in 21 quarters. The position peaked at $7.49M in Q2 2021. 2,279 funds tracked by Wall St. Rank hold NKE as of Q3 2023.

  • Geneva Partners reported no remaining Nike position as of Q3 2023 after selling out during the quarter.
  • Geneva Partners sold 3,053 Nike shares in Q3 2023, an estimated $337K.
  • Geneva Partners first reported a position in Nike in Q2 2018 and held it in 21 quarters.
  • Geneva Partners's Nike position peaked at $7.49M in Q2 2021.
  • 2,279 funds tracked by Wall St. Rank held Nike as of Q3 2023.

Based on Geneva Partners's 13F filing for Q3 2023, filed 25 Oct 2023.